Vera Therapeutics Inc (VERA)
42.31
+2.80
(+7.09%)
USD |
NASDAQ |
May 01, 16:00
42.31
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics Total Return Price: 42.31 for May 1, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 01, 2024 | 42.31 |
| April 30, 2024 | 39.51 |
| April 29, 2024 | 41.38 |
| April 26, 2024 | 39.65 |
| April 25, 2024 | 38.69 |
| April 24, 2024 | 39.95 |
| April 23, 2024 | 39.52 |
| April 22, 2024 | 39.13 |
| April 19, 2024 | 38.00 |
| April 18, 2024 | 39.48 |
| April 17, 2024 | 40.01 |
| April 16, 2024 | 42.57 |
| April 15, 2024 | 46.53 |
| April 12, 2024 | 47.97 |
| April 11, 2024 | 48.82 |
| April 10, 2024 | 41.62 |
| April 09, 2024 | 37.91 |
| April 08, 2024 | 38.63 |
| April 05, 2024 | 37.52 |
| April 04, 2024 | 37.41 |
| April 03, 2024 | 39.60 |
| April 02, 2024 | 40.85 |
| April 01, 2024 | 42.35 |
| March 28, 2024 | 43.12 |
| March 27, 2024 | 43.83 |
| Date | Value |
|---|---|
| March 26, 2024 | 41.58 |
| March 25, 2024 | 41.18 |
| March 22, 2024 | 41.00 |
| March 21, 2024 | 42.87 |
| March 20, 2024 | 45.33 |
| March 19, 2024 | 43.42 |
| March 18, 2024 | 41.47 |
| March 15, 2024 | 43.25 |
| March 14, 2024 | 43.50 |
| March 13, 2024 | 45.23 |
| March 12, 2024 | 44.19 |
| March 11, 2024 | 43.18 |
| March 08, 2024 | 44.30 |
| March 07, 2024 | 43.30 |
| March 06, 2024 | 45.87 |
| March 05, 2024 | 45.15 |
| March 04, 2024 | 46.54 |
| March 01, 2024 | 49.14 |
| February 29, 2024 | 47.08 |
| February 28, 2024 | 45.94 |
| February 27, 2024 | 48.14 |
| February 26, 2024 | 46.35 |
| February 23, 2024 | 47.45 |
| February 22, 2024 | 49.00 |
| February 21, 2024 | 44.55 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
5.41
Minimum
Jan 09 2023
49.14
Maximum
Mar 01 2024
18.58
Average
17.08
Median
Total Return Price Benchmarks
| Vertex Pharmaceuticals Inc | 402.18 |
| Alpine Immune Sciences Inc | 64.60 |
| Fate Therapeutics Inc | 4.09 |
| Checkpoint Therapeutics Inc | 1.39 |
| Mersana Therapeutics Inc | 3.37 |